Dualitas Therapeutics

About Dualitas Therapeutics

Dualitas Therapeutics, founded in 2023, aims to transform the discovery of differentiated bispecific antibody (BsAb) therapies. Using their proprietary DualScreen™ Bispecific Discovery Engine, they operate at a combinatorial scale to uncover novel co-target combinations and cell-surface proximity biology, delivering highly differentiated bispecific candidates for immune and inflammatory diseases.

Products & Services

DualScreen™ Bispecific Discovery Engine:A proprietary platform that screens vast combinations of cell surface targets to identify synergistic bispecific antibodies (BsAbs) with differentiated pharmacology, unlike traditional narrow approaches.

Immune Proximity Engagers:Reusable antibody arms discovered via DualScreen, which can be paired with disease-relevant targets to enhance pharmacologic activity and achieve differentiated efficacy.

Pipeline Programs (DTX-102 and DTX-103):Lead bispecific antibody programs targeting autoimmune (DTX-102) and allergic diseases (DTX-103), demonstrating superior preclinical profiles compared to existing therapies.

Specialties

Bispecific Antibody (BsAb) Discovery Cell-Surface Proximity Biology Immune and Inflammatory Disease Therapies High-Throughput Functional Screening

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 65000000 MR: - FA: $65 million FAN: 65000000	D: 2025-09-16 FD: 2025-09-16	6 investors

Series A Latest

2025-09-16

$65.0M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Rich Murray

Interim Chief Executive Officer and Board Member

G

Greg Lazar

Co-Founder and Chief Scientific Officer

F

Forbes Huang

Co-Founder, Chief Operating Officer & Chief Business Officer

N

Neil Weir

Executive Chairman of the Board

T

Thomas Hudson

Venture Partner, Versant Ventures

A

Alicia Levey

Venture Partner, Versant Ventures

View 6 more team members with Pro

Unlock Full Team Directory

Recent News